AU2003215687A1 - 1,2,4-triazole derivatives with cannabinoid properties - Google Patents
1,2,4-triazole derivatives with cannabinoid propertiesInfo
- Publication number
- AU2003215687A1 AU2003215687A1 AU2003215687A AU2003215687A AU2003215687A1 AU 2003215687 A1 AU2003215687 A1 AU 2003215687A1 AU 2003215687 A AU2003215687 A AU 2003215687A AU 2003215687 A AU2003215687 A AU 2003215687A AU 2003215687 A1 AU2003215687 A1 AU 2003215687A1
- Authority
- AU
- Australia
- Prior art keywords
- triazole derivatives
- cannabinoid
- properties
- cannabinoid properties
- triazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical class C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200200740 | 2002-03-27 | ||
ES200200740A ES2192494B1 (en) | 2002-03-27 | 2002-03-27 | 1,2,4-TRIAZOL DERIVATIVES WITH CANNABINOID PROPERTIES. |
PCT/ES2003/000126 WO2003082833A1 (en) | 2002-03-27 | 2003-03-18 | 1,2,4-triazole derivatives with cannabinoid properties |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003215687A1 true AU2003215687A1 (en) | 2003-10-13 |
Family
ID=28459667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003215687A Abandoned AU2003215687A1 (en) | 2002-03-27 | 2003-03-18 | 1,2,4-triazole derivatives with cannabinoid properties |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003215687A1 (en) |
ES (1) | ES2192494B1 (en) |
WO (1) | WO2003082833A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
WO2004058145A2 (en) | 2002-12-19 | 2004-07-15 | Merck & Co., Inc. | Substituted amides |
US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
MXPA06008391A (en) | 2004-01-28 | 2006-08-25 | Hoffmann La Roche | Novel spiro-pentacyclic compounds. |
TW200602314A (en) | 2004-05-28 | 2006-01-16 | Tanabe Seiyaku Co | A novel pyrrolidine compound and a process for preparing the same |
US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
EP1812418B1 (en) | 2004-11-09 | 2010-10-27 | F. Hoffmann-La Roche AG | Dibenzosuberone derivatives |
US7632837B2 (en) | 2005-06-17 | 2009-12-15 | Bristol-Myers Squibb Company | Bicyclic heterocycles as cannabinoid-1 receptor modulators |
BRPI0613505A2 (en) | 2005-06-30 | 2011-01-11 | Prosidion Ltd | gpcr agonists |
WO2008081208A1 (en) | 2007-01-04 | 2008-07-10 | Prosidion Limited | Piperidine gpcr agonists |
AR064736A1 (en) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | GPCR AGONISTS |
DK2114933T3 (en) | 2007-01-04 | 2012-01-02 | Prosidion Ltd | Piperidine GPCR agonists |
AR064735A1 (en) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | GPCR AGONISTS AND PHARMACEUTICAL COMPOSITION BASED ON THE COMPOUND |
GB0700122D0 (en) | 2007-01-04 | 2007-02-14 | Prosidion Ltd | GPCR agonists |
GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
GB0720390D0 (en) | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
TW201021797A (en) | 2008-12-04 | 2010-06-16 | Nat Univ Tsing Hua | 1,2,3-triazole derivatives as new cannabinoid-1 receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3984558A (en) * | 1973-05-21 | 1976-10-05 | Merck & Co., Inc. | 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators |
JPH08245315A (en) * | 1995-03-16 | 1996-09-24 | Nippon Soda Co Ltd | Triazole derivative and pest control agent |
MY129541A (en) * | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
-
2002
- 2002-03-27 ES ES200200740A patent/ES2192494B1/en not_active Expired - Fee Related
-
2003
- 2003-03-18 WO PCT/ES2003/000126 patent/WO2003082833A1/en not_active Application Discontinuation
- 2003-03-18 AU AU2003215687A patent/AU2003215687A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003082833A1 (en) | 2003-10-09 |
ES2192494B1 (en) | 2005-02-16 |
ES2192494A1 (en) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003215687A1 (en) | 1,2,4-triazole derivatives with cannabinoid properties | |
AU2002349754A1 (en) | Novel 1,2,4-triazole compound | |
AU2003284596A1 (en) | Imidazole derivative, process for producing the same, and use | |
AU2002341195A1 (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives | |
AU2002312883A1 (en) | Substituted cyclohexane-1,4-diamine derivatives | |
PT1471065E (en) | Novel 1,2,4-triazole compound | |
AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
AU2003243637A1 (en) | Cannabinoid receptor agonists | |
AU2001230026A1 (en) | 2,4-diaminothiazole derivatives | |
MXPA03006773A (en) | Imidazole derivatives. | |
AU2003266333A1 (en) | 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties | |
AU2003264207A1 (en) | 1,4-substituted cyclohexane derivatives | |
AU2003247706A1 (en) | 6, 11-4-carbon bridged erythromycin derivatives | |
AU2003273885A1 (en) | Morpholine-bridged indazole derivatives | |
AU2003248537A1 (en) | Bushing | |
AU2002339192A1 (en) | 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors | |
AU2003269949A1 (en) | Substituted 1,4-pyrazine derivatives | |
AU2003225846A1 (en) | Variable response bushing | |
TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
AU2003258598A1 (en) | Substituted 1,2,3,4-tetrahydroquinoline derivatives | |
AU2002953019A0 (en) | Azole derivatives | |
AU2003271171A1 (en) | 2,2-DI-SUBSTITUTED 1Alpha,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE | |
AU2003223100A1 (en) | 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents | |
AU2003255737A1 (en) | Antimicrobial 2, 4-diamino-pteridine derivatives | |
AU2001256791A1 (en) | 5,6-trans-2-alkylvitamin d derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |